The effect of progesterone supplementation in women with threatened miscarriage on fetal fraction in non-invasive prenatal testing: A matched case-control study

Alper İleri1, Suna Yıldırım Karaca1, Hande İleri2, İbrahim Karaca3, Hakan Gölbaşı4, Mehmet Özer4, Adnan Budak1, Yasar Bekir Kutbay5, Altuğ Koç5, Mehmet Özeren1
1Tepecik Education and Research Hospital, Department of Obstetrics and Gynaecology, Izmir, Turkey
2Tepecik Education and Research Hospital, Department of Family Medicine, Izmir, Turkey
3İzmir Bakircay University, Çiğli Education and Research Hospital, Department of Obstetrics and Gynaecology, Izmir, Turkey
4Tepecik Education and Research Hospital, Department of Perinatology, Izmir, Turkey
5Tepecik Education and Research Hospital, Genetic Diagnosis Center, Izmir, Turkey

Tài liệu tham khảo

Qiao, 2019, Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing, Am J Obstet Gynecol, 221, 345.e1, 10.1016/j.ajog.2019.05.023 Deng, 2022, Factors affecting the fetal fraction in noninvasive prenatal screening: a review, Front Pediatr, 10, 1 Hu, 2019, An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study, J Transl Med, 17, 1, 10.1186/s12967-019-1871-x Cserhati, 2021, Calculation of fetal fraction for non-invasive prenatal testing, BioTech, 10, 10.3390/biotech10030017 Guibert, 2003, Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique, Hum Reprod, 18, 1733, 10.1093/humrep/deg320 Wang, 2013, Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma, Prenat Diagn, 33, 662, 10.1002/pd.4119 Scott, 2018, Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy, J Matern Neonatal Med, 31, 1865, 10.1080/14767058.2017.1330881 Ashoor, 2013, Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: Relation to maternal and fetal characteristics, Ultrasound Obstet Gynecol, 41, 26, 10.1002/uog.12331 Yin, 2007, Correlation of maternal plasma total cell-free DNA and fetal DNA levels with short term outcome of first-trimester vaginal bleeding, Hum Reprod, 22, 1736, 10.1093/humrep/dem058 Di Renzo, 2012, The role of progesterone in maternal and fetal medicine, Gynecol Endocrinol, 28, 925, 10.3109/09513590.2012.730576 Haas, 2018, Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology, Cochrane Database Syst Rev, 10 Coomarasamy, 2019, A randomized trial of progesterone in women with bleeding in early pregnancy, N Engl J Med, 380, 1815, 10.1056/NEJMoa1813730 Burke, 2015, Three simple rules to ensure reasonably credible subgroup analyses, BMJ, 35, h5651, 10.1136/bmj.h5651 Giorlandino, 2015, Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study, Am J Obstet Gynecol, 212, 10.1016/j.ajog.2014.10.003 Koc, 2019, Targeted fetal cell-free DNA screening for aneuploidies in 4,594 pregnancies: Single center study, Mol Genet Genomic Med, 7, 1, 10.1002/mgg3.678 Flori, 2004, Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytiotrophoblastic cells. Case report, Hum Reprod, 19, 723, 10.1093/humrep/deh117 Takoudes, 2015, Performance of non-invasive prenatal testing when fetal cell-free DNA is absent, Ultrasound Obstet Gynecol, 45, 112, 10.1002/uog.14715 Cecily, 2015, Use of cell-free DNA in the investigation of intrauterine fetal demise and miscarriage, Obstet Gynecol, 125, 1321, 10.1097/AOG.0000000000000863 Dugoff, 2016, Cell-free DNA fetal fraction and preterm birth, Am J Obstet Gynecol, 215, 10.1016/j.ajog.2016.02.009 Rafaeli-Yehudai, 2018, Maternal total cell free DNA in preeclampsia and fetal growth restriction: evidence of differences in maternal response to abnormal implantation, PLoS One, 13, 10.1371/journal.pone.0200360 Poon, 2013, Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes, Fetal Diagn Ther, 33, 215, 10.1159/000346806 Lim, 2013, Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy, PLoS One, 8, e56787, 10.1371/journal.pone.0056787 Yin, 2023, Correlation of maternal plasma total cell-free DNA and fetal DNA levels with short term outcome of first-trimester vaginal bleeding, Hum Reprod, 22, 10.1093/humrep/dem058 Di Renzo, 2012, The role of progesterone in maternal and fetal medicine, Gynecol Endocrinol, 28, 925, 10.3109/09513590.2012.730576 Druckmann, 2005, Progesterone and the immunology of pregnancy, J Steroid Biochem Mol Biol, 97, 389, 10.1016/j.jsbmb.2005.08.010 Szekeres-Bartho, 2001, Progesterone as an immunomodulatory molecule, Int Immunopharmacol, 1, 1037, 10.1016/S1567-5769(01)00035-2 Fanchin, 2000, Hormonal influence on the uterine contractility during ovarian stimulation, Hum Reprod, 15, 90, 10.1093/humrep/15.suppl_1.90 Liu, 2007, The effects of progesterone on apoptosis in the human trophoblast-derived HTR-8/SV neo cells, Mol Hum Reprod, 13, 869, 10.1093/molehr/gam078